12:00 AM
Sep 14, 2015
 |  BC Week In Review  |  Company News  |  Deals

R-Biopharm, Apogenix deal

R-Biopharm and Apogenix partnered to develop companion diagnostics for Apogenix’s APG101. APG101 is in development to treat solid tumors and malignant hematological diseases and...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >